ARID1A and gastric cancer: ARID1A deficiency impairs the DNA damage checkpoint [46], which is targeted by the MSI mechanism of DNA damage in gastric cancer [43], and ARID1A recruits MSH2 to chromatin during DNA replication and promotes MMR [47].